Divi’s Laboratories has announced its financial results for the quarter and half year ended September 30, 2026. The company reported a consolidated total income of ₹3770 crore for the quarter, a substantial increase compared to the previous year. Profit after tax (PAT) also saw significant growth. Standalone results mirrored this positive trend, reflecting the company’s robust performance in the pharmaceutical sector.
Divi’s Laboratories Announces Strong Financial Performance for Q2 FY27
Divi’s Laboratories Limited has released its financial results for the quarter and half year ended September 30, 2026, showcasing robust growth across key financial metrics. The company reported a consolidated total income of ₹3770 crore for the second quarter of Fiscal Year 2027. This represents a significant increase compared to the consolidated total income of ₹2860 crore reported for the corresponding quarter in the previous year.
Profitability Highlights
Profit before tax (PBT) for the quarter stood at ₹1505 crore, up from ₹912 crore in the prior year’s quarter. Following this, the profit after tax (PAT) for the current quarter was ₹1127 crore, a notable improvement from ₹689 crore in the same period last year. The company also reported a forex gain of ₹24 crore for the quarter.
Half-Yearly Performance
For the half year ended September 30, 2026, Divi’s Laboratories achieved a consolidated total income of ₹6907 crore, an increase from ₹5389 crore in the corresponding half-year of the previous year. The consolidated PBT for the half year was ₹2685 crore, and the consolidated PAT reached ₹2029 crore. The half-year saw a forex gain of ₹17 crore.
Standalone Financial Results
On a standalone basis, the company’s total income for the quarter ended September 30, 2026, was ₹3735 crore, with a PBT of ₹1520 crore and PAT of ₹1140 crore. For the half year ended September 30, 2026, standalone total income was ₹6765 crore, PBT was ₹2685 crore, and PAT was ₹2031 crore. Standalone forex gain for the quarter was ₹27 crore and for the half year was ₹20 crore.
Source: BSE
